Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Cambrium
Cambrium is a next-generation chemical manufacturer specializing in designing and producing high-performance molecules called Supermolecules™. These molecules are created using AI-driven molecular…
Cambrium
Cambrium is a next-generation chemical manufacturer specializing in designing and producing high-performance molecules called Supermolecules™. These molecules are created using AI-driven molecular…
TL;DR
Headquarters: Berlin, Germany
Founded: 2020
Primary offering: AI-designed protein-derived performance molecules ("Supermolecules") and biomaterial manufacturing
Notable product: NovaColl (designed collagen derivative for personal care)
Approx. employees: 26
Company Overview
Problem Domain
Sustainable biomaterials and advanced molecule design to replace or outperform conventional chemical and polymer solutions in personal care and materials markets.
Founded
2020
Industry
Biotechnology Research
Tech Stack
Funding Track Record
€11 million (reported)
Reported seed raise to expand operations and structural-protein programs
$19 million (reported)
Reported Series A
Investor Signal
“Multiple venture investors including Gradient, HOF Capital, Merantix Capital, Valor Equity Partners and others listed as participants”
